Path: utzoo!utgpu!jarvis.csri.toronto.edu!rutgers!cs.utexas.edu!usc!henry.jpl.nasa.gov!elroy.jpl.nasa.gov!ucla-cs!phil@wubios.WUstl.EDU
From: phil@wubios.WUstl.EDU (J. Philip Miller)
Newsgroups: sci.med.aids
Subject: Re: AZT & DDI
Summary: what is the conspiricy?
Message-ID: <26574@shemp.CS.UCLA.EDU>
Date: 20 Aug 89 02:33:25 GMT
References: <26569@shemp.CS.UCLA.EDU>
Sender: news@CS.UCLA.EDU
Reply-To: phil@wubios.WUstl.EDU (J. Philip Miller)
Followup-To: sci.med.aids
Organization: Washington University (St. Louis)
Lines: 31
Approved: aids@cs.ucla.edu
Archive-number: 1145

In article <26569@shemp.CS.UCLA.EDU> lamc!info-aids@apple.com (Info-AIDS Mailer) writes:
>
>This senerio stikes me as a little strange.  Two major drug
>companys in a silent battle.  Both offering hope, if not
>somewhat backhanded.  And where does the FDA fit into all
>this?  Is someone being paid off?  Does Burroughs Wellcome
>feel threatened by DDI?  I feel that some investigation is
>warrented here.
>Scotty
>
excuse me, i am dense [so what else is new :-]

what is the proposed conspiricay?

The AZT is scientific support for a hypothesis that many physicians have had,
that AZT had benefit before symptoms developed - the annoucement that the
trial was positive now makes placebo controlled trials at any stage of the
disease less defesible.

The DDI availability is only for those individuals who are not eligible for
enrollment in other, conventional trials.  The details are still to be
announced.

now what have the FDA and the drug companies cooked up together?

-phil
-- 
-*-*-*-*-*-*-*-*-*-*-*-*-*-*-*-*-*-*-*-*-*-*-*-*-*-*-*-*-*-*-*-*-*
J. Philip Miller - Div of Biostat - Washington Univ Medical School
phil@wubios.WUstl.edu - Internet        phil@wubios.wustl - bitnet
(314) 362-3617                   c90562jm@wuvmd - alternate bitnet